Symbol="VNDA"
AssetType="Common Stock"
Name="Vanda Pharmaceuticals Inc"
Description="Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company is headquartered in Washington, the District of Columbia."
CIK="1347178"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="315148000"
EBITDA="12287000"
PERatio="21.08"
PEGRatio="-2.42"
BookValue="9.39"
DividendPerShare="0"
DividendYield="0"
EPS="0.26"
RevenuePerShareTTM="4.187"
ProfitMargin="0.0625"
OperatingMarginTTM="0.0406"
ReturnOnAssetsTTM="0.0097"
ReturnOnEquityTTM="0.0284"
RevenueTTM="238354000"
GrossProfitTTM="230100000"
DilutedEPSTTM="0.26"
QuarterlyEarningsGrowthYOY="-0.419"
QuarterlyRevenueGrowthYOY="-0.285"
AnalystTargetPrice="7"
TrailingPE="21.08"
ForwardPE="30.3"
PriceToSalesRatioTTM="1.532"
PriceToBookRatio="1.153"
EVToRevenue="0.586"
EVToEBITDA="13.6"
Beta="0.678"
num_52WeekHigh="11.04"
num_52WeekLow="5.26"
num_50DayMovingAverage="6.13"
num_200DayMovingAverage="7.05"
SharesOutstanding="57509000"
DividendDate="None"
ExDividendDate="None"
symbol="VNDA"
open="5.52"
high="5.52"
low="5.26"
price="5.35"
volume="794878.00"
latest_trading_day="2023-08-30"
previous_close="5.48"
change="-0.13"
change_percent="-2.3723%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="50"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="50"
Volume_recent_avg="571881"
Change_recent_avg="-0.02"
Delta_recent_avg="0.23"
Variance_recent_avg="0.11"
Change_ratio_recent_avg="-0.41"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="50"
Aroon_momentum_negative="50"
image_negative_thumbnail_id_1="1152"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0185.jpeg"
image_negative_thumbnail_id_2="1096"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0129.jpeg"
image_neutral_thumbnail_id_1="560"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0039.jpeg"
image_neutral_thumbnail_id_2="574"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0025.jpeg"
image_positive_thumbnail_id_1="630"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0078.jpeg"
image_positive_thumbnail_id_2="642"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0066.jpeg"
image_professor_thumbnail_id_1="1174"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
image_professor_thumbnail_id_2="1189"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0023.jpeg"
